Search

Your search keyword '"Gravina, GL"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Gravina, GL" Remove constraint Author: "Gravina, GL"
233 results on '"Gravina, GL"'

Search Results

1. Optimizing Nozzle Travel Time in Proton Therapy

2. Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR)

3. Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma

4. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy

5. Sexual dysfunctions in people with first-episode psychosis assessed according to a gender perspective

6. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

10. Is testosterone a friend or a foe of the prostate?

19. Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?

20. A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases.

22. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

23. Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes.

24. Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts.

25. [Retracted] Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.

26. Corrigendum: Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.

27. Measurement of PDE5 concentration in human serum: proof-of-concept and validation of methodology in control and prostate cancer patients.

28. Reducing clinical target volume margins for multifocal glioblastoma: a multi-institutional analysis of patterns of recurrence and treatment response.

29. Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

32. HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

33. Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma.

34. Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.

35. A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence.

36. Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge.

37. The botanical drug PBI-05204, a supercritical CO 2 extract of Nerium oleander , sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo .

38. Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.

39. Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results.

40. The Botanical Drug PBI-05204, a Supercritical CO 2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma.

41. CT-guided cryoablation for management of bone metastases: a single center experience and review of the literature.

42. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma.

43. The impact of the incorporation of a feasible postoperative mortality model at the Post-Anaesthestic Care Unit (PACU) on postoperative clinical deterioration: A pragmatic trial with 5,353 patients.

44. Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma.

45. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.

46. Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and Molise.

47. Crocetin Mitigates Irradiation Injury in an In Vitro Model of the Pubertal Testis: Focus on Biological Effects and Molecular Mechanisms.

48. Recommendation for the contouring of limbic system in patients receiving radiation treatment: A pictorial review for the everyday practice and education.

49. Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.

50. Apparent diffusion coefficient magnetic resonance imaging (ADC-MRI) in the axillary breast cancer lymph node metastasis detection: a narrative review.

Catalog

Books, media, physical & digital resources